Alecensa Access Solutions Bridge Program

Funded
About
The Alecensa Access Solutions Bridge Program offers substantial support to patients through the provision of free Alecensa medication while waiting for insurance coverage determination. Intended for those prescribed Alecensa for FDA-approved uses, this program ensures patients with private or commercial insurance can receive necessary treatments promptly.
Insurance requirements: Commercially insured, Underinsured
Enrollment Forms
Enrollment Form
Program Requirements
Valid only for residents in the US and Puerto Rico
Enrollment Required: Yes
Coverage Required: No
Needs Based: No
Activation Required: No
Program Details
Eligible patients taking Alecensa may receive free medicine while awaiting an insurance coverage determination
BOTH the Prescriber Service Form and the Patient Consent Form must be received before ALECENSA Access Solutions can begin helping the patient
HCP must fax the completed Prescriber Service Form to Actemra Access Solutions at 8882494919; call 8882494918 for assistance
Patient must submit the completed Patient Consent Form to Alecensa Access Solutions by texting a photo of the page to 6508771111 or faxing form to 8664807762 (https://www.genentechaccess.com/content/dam/gene/accesssolutions/pdfs/patientconsentform/GenentechAccessSolutionsPatientConsent_Form.pdf)
Patient can also complete the consent form online at https://www.genentechaccess.com/patient/patientconsent.html
For assistance completing patient consent form, call Genentech Access Solutions at 8664222377 6 a.m.–5 p.m. PT, Monday through Friday
For assistance, call 8774363683 6 a.m.–5 p.m. PT, Monday through Friday